Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Polyneuropathy; Drug”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Testing effectiveness (Phase 2)Looking for participantsNCT06798012
What this trial is testing

TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Who this might be right for
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Takeda 36
Early research (Phase 1)WithdrawnNCT03773328
What this trial is testing

A Clinical Trial of CK0801 (a New Drug) In Patients With Treatment-Resistant Guillain-Barré Syndrome (GBS)

Who this might be right for
Guillain-Barré Syndrome
Cellenkos, Inc.
Not applicableStudy completedNCT05945784
What this trial is testing

Exploring Accessible Beauty for Individuals With Upper Extremity Deficits

Who this might be right for
Stroke, IschemicStroke HemorrhagicStroke (CVA) or TIA+11 more
Casa Colina Hospital and Centers for Healthcare 57
Not applicableWithdrawnNCT06052345
What this trial is testing

Paclitaxel-induced Polyneuropathy in Breast Cancer: Early Detection, Risk Factors, Quality of Life and Lifestyle Outcomes

Who this might be right for
Breast NeoplasmsBreast CancerEarly-stage Breast Cancer+5 more
Theodoros Foukakis
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Very early researchUnknownNCT03010241
What this trial is testing

The Multi-Centric Clinical Study of Chinese Medicine Intervention on Diabetes Distal Symmetric Polyneuropathy.

Who this might be right for
Type 2 Diabetes Mellitus
Guang'anmen Hospital of China Academy of Chinese Medical Sciences 188
Early research (Phase 1)Study completedNCT04035135
What this trial is testing

A Clinical Study of ANX005 and IVIG in Subjects With Guillain Barré Syndrome (GBS)

Who this might be right for
Guillain-Barré Syndrome
Annexon, Inc. 14
Testing effectiveness (Phase 2)Study completedNCT04218071
What this trial is testing

Actuate 1901: 9-ING-41 in Myelofibrosis

Who this might be right for
Myelofibrosis
Actuate Therapeutics Inc. 17
Large-scale testing (Phase 3)Ended earlyNCT00809354
What this trial is testing

Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip

Who this might be right for
OsteoarthritisArthritis
Pfizer 2,720
Early research (Phase 1)Study completedNCT04095273
What this trial is testing

Study to Test How Well Patients With Advanced Solid Tumors Respond to Treatment With the Elimusertib in Combination With Pembrolizumab, to Find the Optimal Dose for Patients, How the Drug is Tolerated and the Way the Body Absorbs, Distributes and Discharges the Drug

Who this might be right for
Advanced Solid Tumors
Bayer 56
Not applicableLooking for participantsNCT06377033
What this trial is testing

Using the EHR to Advance Genomic Medicine Across a Diverse Health System

Who this might be right for
Genetic PredispositionParagangliomaPheochromocytoma+7 more
University of Pennsylvania 1,000
Large-scale testing (Phase 3)Study completedNCT02510261
What this trial is testing

The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Participants Who Have Already Been Treated With ALN-TTR02 (Patisiran)

Who this might be right for
Amyloidosis
Alnylam Pharmaceuticals 211
Large-scale testing (Phase 3)Study completedNCT01572727
What this trial is testing

The Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 416
Testing effectiveness (Phase 2)Looking for participantsNCT07558733
What this trial is testing

Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer

Who this might be right for
HR+ HER2- Breast Cancer
Faeth Therapeutics 32
Not applicableStudy completedNCT02146378
What this trial is testing

Vyndaqel Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

Who this might be right for
Transthyretin Familial Amyloid Polyneuropathy
Pfizer 500
Not applicableUnknownNCT02753036
What this trial is testing

Chemotherapy-induced Cognitive Alterations in Recruits With Ovarian and Breast Cancer

Who this might be right for
Cognition DisordersPolyneuropathies
Charite University, Berlin, Germany 72
Testing effectiveness (Phase 2)Study completedNCT01320085
What this trial is testing

A Phase II Study of Single Agent MEK162 in Patients With Advanced Melanoma

Who this might be right for
BRAF or NRAS Mutant Metastatic Melanoma
Pfizer 183
Early research (Phase 1)Study completedNCT00570310
What this trial is testing

Neuropathic Pain Syndrome Patient Study (MK-0000-072)

Who this might be right for
Neuralgia, PostherpeticDiabetic NeuropathyPainful Small-Fiber Neuropathy+1 more
Merck Sharp & Dohme LLC 104
Early research (Phase 1)Study completedNCT02797847
What this trial is testing

A Safety and Tolerability Study of an Investigational Drug, ALN-TTRSC02, in Healthy Subjects

Who this might be right for
Transthyretin-mediated Amyloidosis (ATTR Amyloidosis)
Alnylam Pharmaceuticals 80
Early research (Phase 1)Ended earlyNCT04330625
What this trial is testing

Glucagon Receptor Inhibition to Enable Breast Cancer Patients to Benefit From PI3K Inhibitor Therapy (REMD-477)

Who this might be right for
Hyperglycemia Drug Induced
Duke University 1
Next Page